Scimago Journal & Country Rank
menu
| Title | Type |  SJR |
H index | Total Docs. (2022) | Total Docs. (3years) | Total Refs. (2022) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2022) | %Female (2022) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Vaccines | journal | 1.655 Q1 | 85 | 2178 | 2497 | 113547 | 18817 | 2435 | 7.81 | 52.13 | 47.41 |  |
| 2 | Advances in Therapy | journal | 1.076 Q1 | 83 | 353 | 1036 | 13433 | 4025 | 971 | 3.79 | 38.05 | 41.75 | |
| 3 | Frontiers in Pharmacology | journal | 1.064 Q1 | 154 | 5709 | 7742 | 369866 | 44134 | 7564 | 5.39 | 64.79 | 45.29 | |
| 4 | EJNMMI Radiopharmacy and Chemistry | journal | 0.972 Q1 | 28 | 33 | 97 | 1487 | 488 | 92 | 4.50 | 45.06 | 29.70 | |
| 5 | Inflammopharmacology | journal | 0.932 Q1 | 68 | 188 | 379 | 12130 | 1989 | 367 | 5.27 | 64.52 | 44.07 | |
| 6 | Antibiotics | journal | 0.792 Q2 | 77 | 1838 | 2748 | 110359 | 14048 | 2708 | 5.04 | 60.04 | 48.45 | |
| 7 | Journal of Cardiovascular Development and Disease | journal | 0.725 Q2 | 32 | 462 | 284 | 24006 | 899 | 281 | 2.47 | 51.96 | 37.42 | |
| 8 | Medical Cannabis and Cannabinoids | journal | 0.713 Q2 | 13 | 16 | 38 | 725 | 164 | 32 | 4.20 | 45.31 | 34.67 | |
| 9 | PharmacoEconomics - Open | journal | 0.646 Q2 | 20 | 74 | 197 | 3026 | 419 | 183 | 2.28 | 40.89 | 45.88 | |
| 10 | Chemotherapy | journal | 0.627 Q2 | 61 | 29 | 106 | 1048 | 310 | 100 | 3.41 | 36.14 | 40.18 | |
| 11 | Drugs - Real World Outcomes | journal | 0.564 Q2 | 21 | 61 | 113 | 2190 | 227 | 110 | 1.99 | 35.90 | 44.58 | |
| 12 | Cardiology | journal | 0.486 Q3 | 72 | 74 | 348 | 2286 | 477 | 283 | 1.50 | 30.89 | 28.91 | |
| 13 | WHO Drug Information | journal | 0.123 Q4 | 11 | 4 | 33 | 57 | 6 | 26 | 0.09 | 14.25 | 0.00 | |
| 14 | Frontiers in Medical Technology | journal | 15 | 100 | 113 | 6078 | 315 | 101 | 2.75 | 60.78 | 33.19 | |
Powered by:
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®
Download data